Literature DB >> 15329594

Isoflurane preconditioning induces neuroprotection that is inducible nitric oxide synthase-dependent in neonatal rats.

Ping Zhao1, Zhiyi Zuo.   

Abstract

BACKGROUND: Perinatal stroke is a common human disease. Neonatal brains are immature and engaged in active synaptogenesis. Preconditioning adult rats with the volatile anesthetic isoflurane induces neuroprotection. Whether isoflurane preconditioning induces neuroprotection in neonates is not known.
METHODS: Seven-day-old Sprague-Dawley rats had left common carotid arterial ligation followed by hypoxia with 8% oxygen for 1, 2, or 2.5 h at 37 degrees C. Isoflurane preconditioning with 1 or 1.5% isoflurane for 30 min was performed at 24 h before the brain hypoxia/ischemia. The inducible nitric oxide synthase inhibitor aminoguanidine (200 mg/kg, intraperitoneally) was administered 30 min before the isoflurane pretreatment. The weight ratio of left to right cerebral hemispheres at 7 days after the brain hypoxia/ischemia was calculated. The mortality during the period from cerebral hypoxia/ischemia to 7 days afterwards was monitored. In another experiment, 6-day-old rats were exposed to 1.5% isoflurane for 30 min. The cerebral hemispheres were removed at various time points for Western analysis of inducible nitric oxide synthase.
RESULTS: The mortality was about 40% in neonates with brain hypoxia/ischemia for 2 h or 2.5 h and was not altered by isoflurane preconditioning. The weight ratio of left/right cerebral hemispheres in the survivors was 0.99 +/- 0.02, 0.65 +/- 0.19, and 0.86 +/- 0.15 (n = 7-18) for the rats in control, brain hypoxia/ischemia for 2.5 h, and isoflurane preconditioning plus brain hypoxia/ischemia for 2.5 h groups, respectively (P < 0.05 for the comparisons between control versus brain hypoxia/ischemia and brain hypoxia/ischemia versus isoflurane preconditioning plus brain hypoxia/ischemia). This isoflurane preconditioning-induced neuroprotection was abolished by aminoguanidine (the weight ratio was 0.61 +/- 0.18, n = 12). Isoflurane induced a time-dependent increase in the inducible nitric oxide synthase proteins.
CONCLUSIONS: Isoflurane preconditioning induces neuroprotection in neonatal rats. This neuroprotection is inducible nitric oxide synthase-dependent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15329594     DOI: 10.1097/00000542-200409000-00018

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  59 in total

1.  Isoflurane posttreatment reduces neonatal hypoxic-ischemic brain injury in rats by the sphingosine-1-phosphate/phosphatidylinositol-3-kinase/Akt pathway.

Authors:  Yilin Zhou; Tim Lekic; Nancy Fathali; Robert P Ostrowski; Robert D Martin; Jiping Tang; John H Zhang
Journal:  Stroke       Date:  2010-05-27       Impact factor: 7.914

2.  Intranasal pyrrolidine dithiocarbamate decreases brain inflammatory mediators and provides neuroprotection after brain hypoxia-ischemia in neonatal rats.

Authors:  Zhi Wang; Huijuan Zhao; Shuling Peng; Zhiyi Zuo
Journal:  Exp Neurol       Date:  2013-08-29       Impact factor: 5.330

3.  Isoflurane versus sevoflurane for early brain injury and expression of sphingosine kinase 1 after experimental subarachnoid hemorrhage.

Authors:  Orhan Altay; Hidenori Suzuki; Bilge Nur Altay; Vahit Calisir; Jiping Tang; John H Zhang
Journal:  Neurosci Lett       Date:  2020-06-06       Impact factor: 3.046

Review 4.  Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain.

Authors:  Hideto Kitano; Jeffrey R Kirsch; Patricia D Hurn; Stephanie J Murphy
Journal:  J Cereb Blood Flow Metab       Date:  2006-10-18       Impact factor: 6.200

5.  Inducible nitric oxide synthase promoter polymorphism affords protection against cognitive dysfunction after carotid endarterectomy.

Authors:  Gene T Yocum; John G Gaudet; Susie S Lee; Yaakov Stern; Lauren A Teverbaugh; Robert R Sciacca; Charles W Emala; Donald O Quest; Paul C McCormick; James F McKinsey; Nicholas J Morrissey; Robert A Solomon; E Sander Connolly; Eric J Heyer
Journal:  Stroke       Date:  2009-03-12       Impact factor: 7.914

Review 6.  Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance.

Authors:  R Anne Stetler; Rehana K Leak; Yu Gan; Peiying Li; Feng Zhang; Xiaoming Hu; Zheng Jing; Jun Chen; Michael J Zigmond; Yanqin Gao
Journal:  Prog Neurobiol       Date:  2014-01-02       Impact factor: 11.685

Review 7.  New concepts in treatment of pediatric traumatic brain injury.

Authors:  Jimmy W Huh; Ramesh Raghupathi
Journal:  Anesthesiol Clin       Date:  2009-06

8.  Surpassing boundaries: volatile sedation in the NeuroICU.

Authors:  Federico Villa; Giuseppe Citerio
Journal:  Intensive Care Med       Date:  2012-09-28       Impact factor: 17.440

9.  Anesthetic preconditioning inhibits isoflurane-mediated apoptosis in the developing rat brain.

Authors:  Jun Peng; Julie K Drobish; Ge Liang; Zhen Wu; Chunxia Liu; Donald J Joseph; Hossam Abdou; Maryellen F Eckenhoff; Huafeng Wei
Journal:  Anesth Analg       Date:  2014-10       Impact factor: 5.108

10.  Isoflurane preconditioning increases B-cell lymphoma-2 expression and reduces cytochrome c release from the mitochondria in the ischemic penumbra of rat brain.

Authors:  Liaoliao Li; Longyun Peng; Zhiyi Zuo
Journal:  Eur J Pharmacol       Date:  2008-02-29       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.